作者
Matthew Royle

Matthew Royle, Ph.D.

合伙人

Read More
作者
Matthew Royle

Matthew Royle, Ph.D.

合伙人

Read More

2020年8月7日 | 01:00:50

Biologics and biosimilars litigation update

Tune in to the second in our 2020 webinar series on decisions in the US and Europe impacting biologics and biosimilars.

Many of the top-selling drugs worldwide are biologics and several companies are seeking to produce biosimilars to compete in these lucrative markets. However, companies continue to face a great deal of uncertainty due to unresolved legal questions involving the governing statutes and patent rights.

Session 2 of this series focuses on recent key decisions, including:

  • Recent Federal Circuit decisions involving biologics and biosimilars.
  • Updates in the US “patent thicket” antitrust litigation.
  • Recent developments in Europe including Kymab v Regeneron Supreme Court judgment in the UK.
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

centrifuge-machine
酒店与休闲

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

2020年7月27日
QUICK READ

作者

点击此处了解更多
woman-with-scientific-model
酒店与休闲

Everything biologic and biosimilar in-house counsel need to know about COVID-19

2020年4月29日

作者

点击此处了解更多
酒店与休闲

Webinar: Recent legislative developments affecting biologics and biosimilars

2019年6月30日
Quick read

作者

点击此处了解更多

相关活动